You are here:  » Home   » Products   » Brainostic  


deutschdeutsch
Flash-Player installieren
ScheBo-MediaBox



» Flash-Player installieren
ScheBo® • Biotech AG
Netanyastrasse 3
35394 Giessen, Germany


Phone +49 -(0)641 -4996-0
Fax +49 -(0)641 -4996-77
Email-contact

ScheBo® • Brainostic™

Test for detection of the Specified Risk Material (SRM) of brain and spinal cord in meat products and from swabs


New: GFAP-ELISA Test !

ScheBo® • Biotech AG developed and patented a method to detect high risk material for BSE – brain and spinal cord – in meat products, independent of the species. This procedure is highly specific and sensitive. It allows the detection of central nervous system tissue in all meat products and sausages (raw, cooked or requiring boiling in water), as well as on contaminated surfaces and carcasses. This method is unique because of its sensitive, antibody-based detection of central nervous system tissue even in heat-treated meat products.

  • » Background
    The BSE-Problem

  • » References/literature
    Please find here selected literature - partly as download.

  • » GFAP ELISA Kit
    GFAP-ELISA for the quantitative detection of the Specified Risk Material (SRM) of brain and spinal cord in meat products and from swabs

  • » Laboratory Service
    Our service: send us your samples and we will test them for you (price available on request).


« back


A Decade of UK Success for Schebo Biotech
ScheBo® Biotech UK Limited, a leading provider of unique in-vitro diagnostic tests for the healthcare sector, has just celebrated its 10th Anniversary.
more...
A superior alternative for PLT users: Faecal Pancreatic Elastase Test
Pfizer recommends this test in a letter it sent to pharmacists notifying them about the withdrawal of PLT.
more...
Tumour M2-PK as a stool marker for colorectal cancer
Comparative analysis in a large sample of unselected older adults vs colorectal cancer patients.
more...
Coeliac disease and pancreatic exocrine insufficiency
The data have shown that pancreatic insufficiency, demonstrated by low faecal pancreatic elastase-1 levels, is common in adult coeliac disease patients.
more...
Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK
Fecal tumor M2-PK is an appropriately sensitve tool to pre-select those patients requiring colonoscopy for the further diagnostic confirmation or exclusion of colorectal cancer.
more...
ISO-Certificate
Our ISO-Cerficate as pdf-download.
more...